<?xml version="1.0" encoding="UTF-8"?>
<p id="Par3">First generation Nucleos(t)ide Analogues (NAs), such as lamivudine and adefovir, showed a high antiviral efficacy, but their long-term administration caused an increased viral resistance
 <sup>
  <xref ref-type="bibr" rid="CR3">3</xref>
 </sup>. Lamivudine and adefovir were co-administered until the approval of the second-generation NAs (entecavir and tenofovir) to contrast resistance
 <sup>
  <xref ref-type="bibr" rid="CR4">4</xref>
 </sup>.
</p>
